Ampait, Dexie O.

HRN: 26-46-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2025
CEFTRIAXONE 1G (VIAL)
01/01/2025
01/08/2025
IV DRIP
700mg
Q12hours
PCAP-D
Waiting Final Action 
01/01/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/01/2025
01/08/2025
IV
1130mg
Q6hours
PCAP-D
Waiting Final Action 
01/08/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/08/2025
01/15/2025
INTRAVENOUS
1130 Mg
Every 6 Hours
PCAP-C
Waiting Final Action 
01/19/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
01/19/2025
01/25/2025
IVT
4mL
BID
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: